<p>Select Medical Holdings Co.（纽约证券交易所代码：SEM - 获取免费报告）的股票获得了五家覆盖该公司的券商一致的 “适度买入” 评级，Marketbeat Ratings 报告称。一位分析师给予该股票持有评级，四位分析师给予该公司买入评级。在过去一年中，给予该股票评级的券商的平均 12 个月目标价为 26.00 美元。</p>
<p>获取 <strong>Select Medical</strong> 的提醒：</p>
<p>几位分析师最近对该公司进行了评论。Benchmark 在 2 月 24 日的研究报告中将 Select Medical 的评级从 “持有” 上调至 “买入”，并设定了 23.00 美元的目标价。瑞穗证券在 4 月 16 日的研究报告中开始覆盖 Select Medical，给予 “跑赢大盘” 评级，并设定了 25.00 美元的目标价。华尔街禅在 2 月 21 日的报告中将 Select Medical 的评级从 “持有” 上调至 “买入”。最后，加拿大皇家银行在 5 月 7 日的报告中将 Select Medical 的目标价从 23.00 美元下调至 19.00 美元，并给予 “跑赢大盘” 评级。</p>
<p><strong>查看我们关于 Select Medical 的最新报告</strong></p>
<h2>Select Medical 的内部买卖</h2>
<p>在相关消息中，董事 Parvinderjit S. Khanuja 于 5 月 5 日购买了 21,000 股该公司的股票。该股票的平均购买成本为每股 15.02 美元，总价值为 315,420.00 美元。收购完成后，该董事现在直接持有 65,089 股公司的股票，价值约为 977,636.78 美元。这笔交易使他们的持股增加了 47.63%。该购买在向美国证券交易委员会（SEC）提交的法律文件中披露，相关文件可通过此链接访问。此外，首席执行官 David S. Chernow 于 4 月 28 日的交易中出售了 225,000 股公司的股票。该股票的平均售价为 18.00 美元，总价值为 4,050,000.00 美元。交易完成后，首席执行官现在直接持有 714,516 股公司的股票，价值为 12,861,288 美元。这笔交易使他们的持股减少了 23.95%。该销售的披露信息可以在这里找到。11.60% 的股票由公司内部人士持有。</p>
<h2>对 Select Medical 的对冲基金看法</h2>
<p>大型投资者最近对该股票的持仓进行了调整。Smartleaf Asset Management LLC 在第四季度将其在 Select Medical 的持股增加了 179.0%。Smartleaf Asset Management LLC 现在拥有 2,296 股该健康服务提供商的股票，价值 43,000 美元，此前在该期间内又收购了 1,473 股。凯通国际资产管理有限公司在第一季度将其在 Select Medical 的持股增加了 61.6%。凯通国际资产管理有限公司现在拥有 2,703 股该健康服务提供商的股票，价值 45,000 美元，此前在该期间内又收购了 1,030 股。BI Asset Management Fondsmaeglerselskab A S 在第一季度购买了 Select Medical 的新头寸，价值 60,000 美元。Covestor Ltd 在第四季度将其在 Select Medical 的持股增加了 33.5%。Covestor Ltd 现在拥有 4,955 股该健康服务提供商的股票，价值 93,000 美元，此前在该期间内又收购了 1,244 股。最后，Advisors Asset Management Inc. 在第一季度将其在 Select Medical 的持股增加了 168.2%。Advisors Asset Management Inc. 现在拥有 6,301 股该健康服务提供商的股票，价值 105,000 美元，此前在该期间内又收购了 3,952 股。89.48% 的股票由机构投资者持有。</p>
<h2>Select Medical 股票下跌 0.3%</h2>
<p>SEM 股票在周四开盘价为 15.26 美元。该股票的 50 日简单移动平均线为 15.84 美元，200 日简单移动平均线为 18.61 美元。Select Medical 的 52 周低点为 14.03 美元，52 周高点为 40.98 美元。该公司的债务与股本比率为 1.37，速动比率为 1.13，流动比率为 1.13。该公司的市值为 19.6 亿美元，市盈率为 9.25，市盈增长比率为 0.64，贝塔值为 1.40。</p>
<p>Select Medical（纽约证券交易所代码：SEM - 获取免费报告）最近于 5 月 1 日发布了季度财报。该健康服务提供商报告本季度每股收益为 0.44 美元，低于市场共识预期的 0.45 美元（差额为 0.01 美元）。该公司本季度的收入为 13.5 亿美元，而分析师预期为 14.0 亿美元。Select Medical 的股本回报率为 14.04%，净利润率为 3.23%。该公司的季度收入较去年同期下降了 24.4%。去年同期，该公司每股收益为 0.75 美元。研究分析师平均预计 Select Medical 在当前财政年度的每股收益为 1.17 美元。</p>
<p>Select Medical 宣布其董事会已于 5 月 1 日授权一项股票回购计划，允许公司回购 10 亿美元的股票。该回购授权允许该健康服务提供商通过公开市场购买最多 42.6% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
<h2>Select Medical 宣布分红</h2>
<p>该公司还最近披露了一项季度分红，该分红于 5 月 29 日支付。5 月 15 日的股东获得每股 0.0625 美元的分红。这代表着每年 0.25 美元的分红和 1.64% 的收益率。该分红的除息日期为 5 月 15 日。Select Medical 的分红支付比率（DPR）为 18.66%。</p>
<h2>Select Medical 公司简介</h2>
<p>（获取免费报告）</p>
<p>选择医疗控股公司通过其子公司在美国运营重症恢复医院、康复医院、门诊康复诊所和职业健康中心。它分为四个业务部门：重症恢复医院、康复医院、门诊康复和 Concentra。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们认为比选择医疗更好的股票</li>
<li>消费者非必需品股票解析</li>
<li>Intuit 的人工智能热潮：股票飙升，但投资者应该暂停吗？</li>
<li>低市盈率成长股：解锁投资机会</li>
<li>强分析师评级的顶级分红股票</li>
<li>2022-2025 年股市假期 - 纽约证券交易所和纳斯达克将何时关闭</li>
<li>Robinhood 股票持续给投资者提供购买理由</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNFTQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNFTQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在选择医疗吗？</h2>
<p>在考虑选择医疗之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而选择医疗并不在名单上。</p>
<p>虽然选择医疗目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Select医药控股

<p>Select Medical Holdings Co.（纽约证券交易所代码：SEM）获得了五家券商的 “适度买入” 共识评级。一位分析师将其评级为持有，四位分析师将其评级为买入，12 个月的平均目标价为 26.00 美元。最近的分析师行动包括 Benchmark 将其评级上调至买入，目标价为 23.00 美元，以及瑞穗开始覆盖，目标价为 25.00 美元。内部交易方面，一位董事购买了 21,000 股，而首席执行官出售了 225,000 股。该股票目前下跌 0.3%，交易价格为 15.26 美元，市值为 19.6 亿美元</p>

<p>Shares of Select Medical Holdings Co. (NYSE:SEM - Get Free Report) have received a consensus rating of &#34;Moderate Buy&#34; from the five brokerages that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $26.00.</p>
<div class="lb-trans"><p>Select Medical Holdings Co.（纽约证券交易所代码：SEM - 获取免费报告）的股票获得了五家覆盖该公司的券商一致的 “适度买入” 评级，Marketbeat Ratings 报告称。一位分析师给予该股票持有评级，四位分析师给予该公司买入评级。在过去一年中，给予该股票评级的券商的平均 12 个月目标价为 26.00 美元。</p>
</div><p>Get <strong>Select Medical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Select Medical</strong> 的提醒：</p>
</div><p>Several analysts have recently commented on the company. Benchmark raised Select Medical from a &#34;hold&#34; rating to a &#34;buy&#34; rating and set a $23.00 price objective for the company in a research note on Monday, February 24th. Mizuho started coverage on Select Medical in a research note on Wednesday, April 16th. They issued an &#34;outperform&#34; rating and a $25.00 price objective for the company. Wall Street Zen raised Select Medical from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Friday, February 21st. Finally, Royal Bank of Canada reduced their target price on Select Medical from $23.00 to $19.00 and set an &#34;outperform&#34; rating for the company in a report on Wednesday, May 7th.</p>
<div class="lb-trans"><p>几位分析师最近对该公司进行了评论。Benchmark 在 2 月 24 日的研究报告中将 Select Medical 的评级从 “持有” 上调至 “买入”，并设定了 23.00 美元的目标价。瑞穗证券在 4 月 16 日的研究报告中开始覆盖 Select Medical，给予 “跑赢大盘” 评级，并设定了 25.00 美元的目标价。华尔街禅在 2 月 21 日的报告中将 Select Medical 的评级从 “持有” 上调至 “买入”。最后，加拿大皇家银行在 5 月 7 日的报告中将 Select Medical 的目标价从 23.00 美元下调至 19.00 美元，并给予 “跑赢大盘” 评级。</p>
</div><p><strong>Check Out Our Latest Report on Select Medical</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Select Medical 的最新报告</strong></p>
</div><h2>Insider Buying and Selling at Select Medical</h2>
<div class="lb-trans"><h2>Select Medical 的内部买卖</h2>
</div><p>In related news, Director Parvinderjit S. Khanuja purchased 21,000 shares of the business's stock in a transaction dated Monday, May 5th. The stock was purchased at an average cost of $15.02 per share, with a total value of $315,420.00. Following the completion of the acquisition, the director now directly owns 65,089 shares of the company's stock, valued at approximately $977,636.78. The trade was a 47.63% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO David S. Chernow sold 225,000 shares of the firm's stock in a transaction on Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the transaction, the chief executive officer now directly owns 714,516 shares of the company's stock, valued at $12,861,288. The trade was a 23.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.60% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，董事 Parvinderjit S. Khanuja 于 5 月 5 日购买了 21,000 股该公司的股票。该股票的平均购买成本为每股 15.02 美元，总价值为 315,420.00 美元。收购完成后，该董事现在直接持有 65,089 股公司的股票，价值约为 977,636.78 美元。这笔交易使他们的持股增加了 47.63%。该购买在向美国证券交易委员会（SEC）提交的法律文件中披露，相关文件可通过此链接访问。此外，首席执行官 David S. Chernow 于 4 月 28 日的交易中出售了 225,000 股公司的股票。该股票的平均售价为 18.00 美元，总价值为 4,050,000.00 美元。交易完成后，首席执行官现在直接持有 714,516 股公司的股票，价值为 12,861,288 美元。这笔交易使他们的持股减少了 23.95%。该销售的披露信息可以在这里找到。11.60% 的股票由公司内部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Select Medical</h2>
<div class="lb-trans"><h2>对 Select Medical 的对冲基金看法</h2>
</div><p>Large investors have recently made changes to their positions in the stock. Smartleaf Asset Management LLC boosted its holdings in shares of Select Medical by 179.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock worth $43,000 after acquiring an additional 1,473 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Select Medical by 61.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,703 shares of the health services provider's stock worth $45,000 after acquiring an additional 1,030 shares during the period. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of Select Medical in the first quarter worth $60,000. Covestor Ltd boosted its holdings in shares of Select Medical by 33.5% in the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock worth $93,000 after acquiring an additional 1,244 shares during the period. Finally, Advisors Asset Management Inc. boosted its holdings in shares of Select Medical by 168.2% in the first quarter. Advisors Asset Management Inc. now owns 6,301 shares of the health services provider's stock worth $105,000 after acquiring an additional 3,952 shares during the period. 89.48% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>大型投资者最近对该股票的持仓进行了调整。Smartleaf Asset Management LLC 在第四季度将其在 Select Medical 的持股增加了 179.0%。Smartleaf Asset Management LLC 现在拥有 2,296 股该健康服务提供商的股票，价值 43,000 美元，此前在该期间内又收购了 1,473 股。凯通国际资产管理有限公司在第一季度将其在 Select Medical 的持股增加了 61.6%。凯通国际资产管理有限公司现在拥有 2,703 股该健康服务提供商的股票，价值 45,000 美元，此前在该期间内又收购了 1,030 股。BI Asset Management Fondsmaeglerselskab A S 在第一季度购买了 Select Medical 的新头寸，价值 60,000 美元。Covestor Ltd 在第四季度将其在 Select Medical 的持股增加了 33.5%。Covestor Ltd 现在拥有 4,955 股该健康服务提供商的股票，价值 93,000 美元，此前在该期间内又收购了 1,244 股。最后，Advisors Asset Management Inc. 在第一季度将其在 Select Medical 的持股增加了 168.2%。Advisors Asset Management Inc. 现在拥有 6,301 股该健康服务提供商的股票，价值 105,000 美元，此前在该期间内又收购了 3,952 股。89.48% 的股票由机构投资者持有。</p>
</div><h2>Select Medical Stock Down 0.3%</h2>
<div class="lb-trans"><h2>Select Medical 股票下跌 0.3%</h2>
</div><p>SEM stock opened at $15.26 on Thursday. The stock's 50 day simple moving average is $15.84 and its 200 day simple moving average is $18.61. Select Medical has a fifty-two week low of $14.03 and a fifty-two week high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The company has a market cap of $1.96 billion, a P/E ratio of 9.25, a price-to-earnings-growth ratio of 0.64 and a beta of 1.40.</p>
<div class="lb-trans"><p>SEM 股票在周四开盘价为 15.26 美元。该股票的 50 日简单移动平均线为 15.84 美元，200 日简单移动平均线为 18.61 美元。Select Medical 的 52 周低点为 14.03 美元，52 周高点为 40.98 美元。该公司的债务与股本比率为 1.37，速动比率为 1.13，流动比率为 1.13。该公司的市值为 19.6 亿美元，市盈率为 9.25，市盈增长比率为 0.64，贝塔值为 1.40。</p>
</div><p>Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.01). The company had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.40 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The business's revenue for the quarter was down 24.4% compared to the same quarter last year. During the same period last year, the company earned $0.75 earnings per share. On average, research analysts expect that Select Medical will post 1.17 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Select Medical（纽约证券交易所代码：SEM - 获取免费报告）最近于 5 月 1 日发布了季度财报。该健康服务提供商报告本季度每股收益为 0.44 美元，低于市场共识预期的 0.45 美元（差额为 0.01 美元）。该公司本季度的收入为 13.5 亿美元，而分析师预期为 14.0 亿美元。Select Medical 的股本回报率为 14.04%，净利润率为 3.23%。该公司的季度收入较去年同期下降了 24.4%。去年同期，该公司每股收益为 0.75 美元。研究分析师平均预计 Select Medical 在当前财政年度的每股收益为 1.17 美元。</p>
</div><p>Select Medical declared that its Board of Directors has authorized a stock repurchase plan on Thursday, May 1st that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the health services provider to purchase up to 42.6% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's management believes its shares are undervalued.</p>
<div class="lb-trans"><p>Select Medical 宣布其董事会已于 5 月 1 日授权一项股票回购计划，允许公司回购 10 亿美元的股票。该回购授权允许该健康服务提供商通过公开市场购买最多 42.6% 的股份。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
</div><h2>Select Medical Announces Dividend</h2>
<div class="lb-trans"><h2>Select Medical 宣布分红</h2>
</div><p>The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were issued a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.64%. The ex-dividend date of this dividend was Thursday, May 15th. Select Medical's dividend payout ratio (DPR) is 18.66%.</p>
<div class="lb-trans"><p>该公司还最近披露了一项季度分红，该分红于 5 月 29 日支付。5 月 15 日的股东获得每股 0.0625 美元的分红。这代表着每年 0.25 美元的分红和 1.64% 的收益率。该分红的除息日期为 5 月 15 日。Select Medical 的分红支付比率（DPR）为 18.66%。</p>
</div><h2>Select Medical Company Profile</h2>
<div class="lb-trans"><h2>Select Medical 公司简介</h2>
</div><p>(Get Free Report</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.</p>
<div class="lb-trans"><p>选择医疗控股公司通过其子公司在美国运营重症恢复医院、康复医院、门诊康复诊所和职业健康中心。它分为四个业务部门：重症恢复医院、康复医院、门诊康复和 Concentra。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Select Medical</li>
<li>Consumer Discretionary Stocks Explained</li>
<li>Intuit's AI Boom: Stock Soaring, But Should Investors Hit Pause?</li>
<li>Low PE Growth Stocks: Unlocking Investment Opportunities</li>
<li>Top Dividend Plays With Strong Analyst Ratings</li>
<li>Stock Market Holidays 2022-2025 - Here’s When the NYSE and NASDAQ Will be Closed</li>
<li>Robinhood Stock Keeps Giving Investors Reasons To Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比选择医疗更好的股票</li>
<li>消费者非必需品股票解析</li>
<li>Intuit 的人工智能热潮：股票飙升，但投资者应该暂停吗？</li>
<li>低市盈率成长股：解锁投资机会</li>
<li>强分析师评级的顶级分红股票</li>
<li>2022-2025 年股市假期 - 纽约证券交易所和纳斯达克将何时关闭</li>
<li>Robinhood 股票持续给投资者提供购买理由</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVNFTQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=SEM"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Select Medical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在选择医疗吗？</h2>
</div><p>Before you consider Select Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑选择医疗之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而选择医疗并不在名单上。</p>
</div><p>While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然选择医疗目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

分析师一致推荐 Select Medical Holdings Co.（纽约证券交易所代码：SEM）为 “适度买入”